Principal Street Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
31,104
+20,909
| +205% | +$1.46M | 0.21% | 72 |
|
|
2025
Q1 | $749K | Buy |
10,195
+1,281
| +14% | +$94.2K | 0.14% | 91 |
|
|
2024
Q4 | $584K | Sell |
8,914
-9,220
| -51% | -$604K | 0.11% | 114 |
|
|
2024
Q3 | $1.41M | Buy |
18,134
+8,986
| +98% | +$701K | 0.23% | 70 |
|
|
2024
Q2 | $713K | Hold |
9,148
| – | – | 0.13% | 93 |
|
|
2024
Q1 | $705K | Buy |
9,148
+447
| +5% | +$34.4K | 0.13% | 103 |
|
|
2023
Q4 | $586K | Sell |
8,701
-9,369
| -52% | -$631K | 0.14% | 101 |
|
|
2023
Q3 | $1.22M | Buy |
18,070
+9,288
| +106% | +$629K | 0.24% | 74 |
|
|
2023
Q2 | $629K | Buy |
8,782
+68
| +0.8% | +$4.87K | 0.15% | 97 |
|
|
2023
Q1 | $605K | Sell |
8,714
-317
| -4% | -$22K | 0.15% | 98 |
|
|
2022
Q4 | $612K | Sell |
9,031
-715
| -7% | -$48.5K | 0.15% | 99 |
|
|
2022
Q3 | $534K | Sell |
9,746
-271
| -3% | -$14.8K | 0.14% | 118 |
|
|
2022
Q2 | $662K | Buy |
10,017
+280
| +3% | +$18.5K | 0.17% | 94 |
|
|
2022
Q1 | $646K | Buy |
+9,737
| New | +$646K | 0.15% | 118 |
|
|
2021
Q4 | – | Sell |
-8,982
| Closed | -$539K | – | 196 |
|
|
2021
Q3 | $539K | Buy |
8,982
+2,644
| +42% | +$159K | 0.15% | 114 |
|
|
2021
Q2 | $380K | Buy |
6,338
+436
| +7% | +$26.1K | 0.1% | 149 |
|
|
2021
Q1 | $293K | Buy |
5,902
+47
| +0.8% | +$2.33K | 0.04% | 174 |
|
|
2020
Q4 | $293K | Hold |
5,855
| – | – | 0.09% | 148 |
|
|
2020
Q3 | $321K | Buy |
+5,855
| New | +$321K | 0.11% | 119 |
|
|
2020
Q2 | – | Sell |
-8,147
| Closed | -$364K | – | 129 |
|
|
2020
Q1 | $364K | Hold |
8,147
| – | – | 0.15% | 100 |
|
|
2019
Q4 | $406K | Hold |
8,147
| – | – | 0.09% | 147 |
|
|
2019
Q3 | $363K | Buy |
8,147
+36
| +0.4% | +$1.6K | 0.09% | 146 |
|
|
2019
Q2 | $335K | Buy |
+8,111
| New | +$335K | 0.18% | 118 |
|